Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Impact of early relapse within 24 months after first-line systemic therapy (POD24) on outcomes in patients with marginal zone lymphoma: A US multisite study.
J Hematol Oncol. 2023 May 8;16(1):49. doi: 10.1186/s13045-023-01448-y.
J Hematol Oncol. 2023.
PMID: 37158890
Free PMC article.
A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma.
Hanel W, Shindiapina P, Bond DA, Sawalha Y, Epperla N, Voorhees T, Welkie RL, Huang Y, Behbehani GK, Zhang X, McLaughlin E, Chan WK, Brammer JE, Jaglowski S, Reneau JC, Christian BA, William BM, Cohen JB, Baiocchi RA, Maddocks K, Blum KA, Alinari L.
Hanel W, et al. Among authors: welkie rl.
Cancers (Basel). 2023 Feb 24;15(5):1437. doi: 10.3390/cancers15051437.
Cancers (Basel). 2023.
PMID: 36900230
Free PMC article.
Item in Clipboard
Burden of employment loss and absenteeism in adults and caregivers of children with sickle cell disease.
Gordon RD, Welkie RL, Quaye N, Hankins JS, Kassim AA, Thompson AA, Treadwell M, Lin CJ, Cronin RM.
Gordon RD, et al. Among authors: welkie rl.
Blood Adv. 2024 Mar 12;8(5):1143-1150. doi: 10.1182/bloodadvances.2023012002.
Blood Adv. 2024.
PMID: 38231083
Free PMC article.
Item in Clipboard
Impact of circulating lymphoma cells at diagnosis on outcomes in patients with marginal zone lymphoma: a multicenter cohort study.
Annunzio K, Grover NS, Welkie RL, Torka P, Watkins MP, Anampa-Guzmán A, Tavakkoli M, Oh TS, Reves H, Jones D, Hanel W, Christian B, Ramakrishnan Geethakumari P, Karmali R, Barta SK, Bartlett NL, Olszewski AJ, Epperla N.
Annunzio K, et al. Among authors: welkie rl.
Blood Adv. 2023 Nov 28;7(22):6839-6843. doi: 10.1182/bloodadvances.2023011288.
Blood Adv. 2023.
PMID: 37792806
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite